Three quarters of patients with early inflammatory arthritis who respond to a combination of infliximab and methotrexate can expect to have a second drug-free year in remission, according to European research. The Definitive Intervention in New Onset Rheumatoid Arthritis (DINORA) trial randomised 90 patients with synovial swelling in at least two joints for two to ...
Window of opportunity for anti-TNF in early inflammatory arthritis
By Mardi Chapman
3 Sep 2018